Antibody production by administration of biodegradable granules incorporating antigen through different injection routes

Journal of Controlled Release

Volumn 40, Issue 1-2, 1996, Pages 11-21

  Nakaoka, Ryusuke ^a   Tabata, Yasuhiko ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen release; Biodegradable granule; Immunological adjuvant; Injection site; Poly(DL lactic acid)

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; OVALBUMIN; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG GRANULATION; DRUG GRANULE; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029890266     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00133-6     Document Type: Article

References (20)

1. H.S. Warren, F.R. Vogel and L.A. Chedid, Current status of immunological adjuvants, Annu. Rev. Immunol. 4 (1986) 369-388.
2. W.J. Herbert, The mode of action of mineral-oil emulsion adjuvants on antibody production in mice, Immunology 14 (1968) 301-318.
3. D.A. Eppstein, N.E. Byars and A.C. Allison, New adjuvants for vaccines containing protein antigens, Adv. Drug Deliv. Rev. 4 (1990) 233-253.
4. J. Kreuter, Possibilities of using nanoparticles as carriers for drugs and vaccines, J. Microencapsul. 5 (1988) 115-127.
5. J.H. Eldridge, J.K. Staas, D. Chen. P.A. Marx, T.R. Tice and R.M. Gilley, New advances in vaccine delivery systems. Sem. Hematol. 30 (Suppl. 4) (1993) 16-25.
6. R. Langer, New methods of drug delivery, Science 249 (1990) 1527-1533.
7. W. Morris, M.C. Steinhoff and P.K. Russell, Potential of polymer microencapsulation technology for vaccine innovation, Vaccine 12 (1994) 5-11.
8. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice and R.M. Gilley, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun. 59 (1991) 2978-2986.
9. D.T. O'Hagen, D. Rahman, J.P. Mcgee, H. Jeffery, M.C. Davis, P. Williams, S.S. Davis and S.J. Challacombe, Biodegradable microparticles as controlled release antigen delivery systems. Immunology 73 (1991) 239-242.
10. A.J. Almeida, H.O. Alpar and M.R.W. Brown, Immune responses to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs, J. Pharm. Pharmacol. 45 (1993) 198-203.
11. M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber and R. Langer, Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12 (1994) 299-306.
12. R. Nakaoka, Y. Tabata and Y. Ikada, Enhanced antibody production through sustained antigen release from biodegradable granules, J. Control. Release (1995) in press.
13. Y. Tabata and Y. Ikada, Macrophage phagocytosis of biodegradable microspheres composed of L-lactic/glycolic acid homo-and copolymers, J. Biomed. Mater. Res. 22 (1988) 837-858.
14. Y. Tabata, Y. Takebayashi, T. Ueda and Y. Ikada, A formulation method using DL-lactic acid oligomer for protein release with reduced initial burst, J. Control. Release 23 (1993) 55-64.
15. R. McGrath, Protein measurement by the ninhydrin determinationof amino acids released by alkaline hydrolysis, Anal. Biochem. 49 (1972) 95-102.
16. R.J. Benjamin, S.P. Cobbold, M.R. Clark and H. Waldmann, Tolerance to rat monoclonal antibodies. Implication for serotherapy, J. Exp. Med. 163 (1986) 1539-1551.
17. P.A. Moore, Preparation of whole blood for liquid scintillation counting, Clin. Chem. 27 (1981) 609-611.
18. M. Nishikawa, F. Yamashita, Y. Takakura, M. Hashida and H. Sezaki, Demonstration of the receptor-mediated hepatic uptake of dextran in mice, J. Pharm. Pharmacol. 44 (1992) 396-401.
19. E.F. Unanue, The regulatory role of macrophages in antigenic stimulation. Part Two: Symbiotic relationship between lymphocytes and macrophages, Adv. Immunol. 31 (1981) 1.
20. S.B. Mizel, J.M. Dayer, S.M. Krane and S.E. Mergenhagen, Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (interleukin 1), Proc. Natl. Acad. Sci. USA 78 (1981) 2474-2477.